文献速递慢阻肺

支气管基因表达特征与COPD患者及高危人群后续FEV1下降速率相关

Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD.
PubMed 文献 · Thorax · 2021-05-10

研究在134例有/无COPD的吸烟者中,用支气管刷检基因表达谱识别与FEV1下降速率相关的差异,发现171个基因表达差异相关,并在46例COPD患者支气管活检独立数据集中验证;该特征富集于XBP1调控基因和黏蛋白相关基因,提示气道上皮分子过程可早期识别FEV1快速下降高危者。

要点

  • 支气管刷检基因表达特征与后续FEV1下降速率相关,含171个基因。
  • 该特征在独立COPD活检数据集中得到验证(p=0.018)。
  • 快速下降相关基因富集于XBP1调控基因和黏蛋白相关基因。

核心结论

  • 气道上皮基因表达特征与后续FEV1下降速率相关,并可在独立数据集中重复。
  • 该特征涉及XBP1调控基因和黏蛋白相关基因,提示未折叠蛋白反应和黏蛋白生成相关分子过程。

研究设计与样本

  • 研究对象为有/无COPD的吸烟者,基线支气管刷检行Affymetrix微阵列基因表达检测,并纵向随访肺功能(n=134;平均随访6.38±2.48年)。
  • 采用线性模型识别与FEV1下降速率相关的基因表达谱。
  • 在独立COPD患者支气管活检数据集中重复验证(n=46;平均随访6.76±1.32年)。

主要发现

  • 171个基因的表达差异与FEV1下降速率相关(错误发现率<0.05)。
  • FEV1下降特征在独立COPD活检数据集中得到重复(p=0.018)。
  • 在FEV1下降较快者中升高的基因,在两个独立数据集中显著富集于XBP1调控所改变的基因(GSEA p<0.05)。
  • 上述基因还富集于黏蛋白相关基因(GSEA p<0.05)。

临床怎么用

  • 该特征有望作为FEV1下降的候选指标,辅助早期识别有/无COPD的吸烟者中FEV1快速下降高危者。
  • XBP1调控基因和黏蛋白相关基因可作为后续机制研究与标志物开发的候选方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: COPD is characterised by progressive lung function decline. Leveraging prior work demonstrating bronchial airway COPD-associated gene expression alterations, we sought to determine if there are alterations associated with differences in the rate of FEV1 decline. METHODS: We examined gene expression among ever smokers with and without COPD who at baseline had bronchial brushings profiled by Affymetrix microarrays and had longitudinal lung function measurements (n=134; mean follow-up=6.38±2.48 years). Gene expression profiles associated with the rate of FEV1 decline were identified by linear modelling. RESULTS: Expression differences in 171 genes were associated with rate of FEV1 decline (false discovery rate <0.05). The FEV1 decline signature was replicated in an independent dataset of bronchial biopsies from patients with COPD (n=46; p=0.018; mean follow-up=6.76±1.32 years). Genes elevated in individuals with more rapid FEV1 decline are significantly enriched among the genes altered by modulation of XBP1 in two independent datasets (Gene Set Enrichment Analysis (GSEA) p<0.05) and are enriched in mucin-related genes (GSEA p<0.05). CONCLUSION: We have identified and replicated an airway gene expression signature associated with the rate of FEV1 decline. Aspects of this signature are related to increased expression of XBP1-regulated genes, a transcription factor involved in the unfolded protein response, and genes related to mucin production. Collectively, these data suggest that molecular processes related to the rate of FEV1 decline can be detected in airway epithelium, identify a possible indicator of FEV1 decline and make it possible to detect, in an early phase, ever smokers with and without COPD most at risk of rapid FEV1 decline.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Becker EJ, Faiz A, van den Berge M, et al. Bronchial gene expression signature associated with rate of subsequent FEV1 decline in individuals with and at risk of COPD. Thorax. 2021. PMID: 33972452. doi:10.1136/thoraxjnl-2019-214476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。